beginning
ISLAMABAD
Searle Company Limited (SEARL) has become Pakistan’s first pharmaceutical company to register its manufacturing facility in the United Arab Emirates (UAE) market. The company received approval from the UAE Ministry of Health and Prevention and registered its manufacturing facility in the United Arab Emirates.
This significant achievement positions Searle as the first pharmaceutical company from Pakistan to have its manufacturing facility registered in the UAE.
“Yet another achievement. Pakistani pharma is now entering stringent
markets. Searle’s recent certification is testimony to our commitment to
boost pharma exports,” Chief Executive Officer, the Drug Regulatory
Authority of Pakistan (DRAP), Asim Rauf said in a tweet.
“This is a great breakthrough and important development that will bring
not only revenue and jobs but opens international drug business avenues
for Pakistani industry.”
